May 18, 2022 at 01:03PM ReFacto

Product approval information for Control and prevention of hemorrhagic episodes and for short-term routine and surgical prophylaxis in patients with hemophilia A.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/yHZzC5m